$RMTI Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.04 • Reported revenue of $17.34M down -8.34% YoY • Rockwell Medical anticipates 2026 net sales between $70.0M and $75.0M, with gross margin expected to range from 18% to 22%. Adjusted EBITDA is projected to be $1.0M to $2.0M.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.